LabLogic announces regional partnership to support growth of radiopharmaceuticals in Latin America

07/07/2025

Acrux Radiopharma Consulting is now providing service and support across the region

As radiopharmaceuticals continues to expand globally, LabLogic is proud to partner with Acrux Radiopharma Consulting. Based in Chile, Acrux becomes our latest international representative to offer technical support and expertise for LabLogic’s suite of solutions throughout Latin America.

This partnership comes at a time of significant growth in radiopharmaceuticals across the region. Driven by increasing cancer incidence, aging populations, and national healthcare initiatives, many countries throughout Latin America are investing heavily in nuclear medicine with support from international bodies such as the International Atomic Energy Agency (IAEA).

About Acrux

Acrux Radiopharma Consulting was founded with a mission to support the radiopharmaceutical industry and nuclear medicine facilities by delivering customised solutions and experienced technical service. With a multilingual team of technical experts fluent in both Spanish and Portuguese, Acrux is strongly positioned to serve the diverse needs of healthcare providers and research institutions across this part of the world.

Alongside LabLogic, Acrux also partners with IBA, the world’s leading supplier of cyclotrons, and Tema Sinergie, one of the leading producers of systems for handling and dosing radiopharmaceuticals. This means Acrux can now streamline customer support across multiple products.

Acrux’s Marcelo Ilhéu (left) and Alejandro Muro (right) with LabLogic Service Engineer Sam Marshall (centre) during recent training at LabLogic’s head office earlier this year.

"This new partnership will allow us to effectively support the radiopharmaceutical industry in our region ..."

Acrux Co-Founder & Technical Director Marcelo Ilheu said, “The Latin American radiopharmaceutical market is poised for continued growth, with a focus on expanding the availability of PET radiopharmaceuticals, theranostic solutions and radioligand therapies for precision oncology and chronic disease management.

"This new partnership will allow us to effectively support the radiopharmaceutical industry in our region, assuring regulatory compliance, highest quality, and reliable operation of the serviced equipment.”

Supporting emerging markets

As a global leader in the provision of instruments and software for nuclear medicine and radiopharmacy, LabLogic welcomes this collaboration as a key step toward further supporting emerging markets. With Acrux’s broad technical experience in Latin America, customers will benefit from local expertise and responsive support tailored to their specific needs.

Together, LabLogic and Acrux aim to support the safe and effective use of radiopharmaceuticals, contributing to improved patient outcomes across the region.

Find out more